Advances in ORMDL Research in Malignant Tumors: A Review
Hao Wang1, Zhongquan Yi2, Song Yan3
1Department of Cardiothoracic Surgery, Affiliated Hospital 6 of Nantong University, Yancheng Third People's Hospital, Yancheng, 224000, People's Republic of China.
Abstract:
ORMDL proteins (ORMDL1, ORMDL2, ORMDL3) are transmembrane proteins in the endoplasmic reticulum (ER) that regulate sphingolipid metabolism, maintain ER homeostasis, and modulate cellular stress responses. They influence cell proliferation, apoptosis, and metabolic balance. Recent studies have highlighted the altered expression and function of ORMDL proteins in various tumors, including breast cancer, DLBCL, colorectal cancer, and lung cancer. ORMDLs negatively regulate serine palmitoyltransferase (SPT), affecting ceramide and sphingolipid metabolism, which plays a key role in tumor cell proliferation, invasiveness, and resistance to therapy. The dysregulation of ORMDL expression may disrupt sphingolipid metabolism, trigger ER stress, and impair autophagy. Investigating ORMDL functions in cancer could lead to novel insights into tumor development and progression. ORMDL expression may serve as a potential biomarker for cancer diagnosis, prognosis, and therapeutic response prediction. Targeting ORMDL or its metabolic networks offers promising strategies for cancer therapy. Although research on ORMDLs is still in its early stages, further studies are needed to explore their roles in the tumor microenvironment, interactions with the immune system, and applications in personalized medicine. A deeper understanding of ORMDL proteins will enhance tumor diagnosis, treatment, and the development of new therapeutic approaches.
Insights
ORMDL proteins regulate sphingolipid metabolism and endoplasmic reticulum homeostasis. Their altered expression in cancer suggests potential as diagnostic biomarkers and therapeutic targets for improved tumor treatment.
Area of Science:
- Cellular Biology
- Oncology
- Biochemistry
Background:
- ORMDL proteins (ORMDL1-3) are endoplasmic reticulum (ER) transmembrane proteins regulating sphingolipid metabolism and cellular stress responses.
- Altered ORMDL expression is observed in various cancers, impacting cell proliferation, apoptosis, and metabolic balance.
- ORMDLs' role in negatively regulating serine palmitoyltransferase (SPT) affects ceramide metabolism crucial for tumor progression.
Purpose of the Study:
- To investigate the role of ORMDL proteins in cancer development and progression.
- To explore ORMDL proteins as potential biomarkers for cancer diagnosis, prognosis, and therapeutic response.
- To evaluate targeting ORMDL proteins or associated metabolic networks as a cancer therapy strategy.
Main Methods:
- Analysis of ORMDL protein expression in various tumor types.
- Investigation of ORMDL-mediated regulation of sphingolipid metabolism and ER homeostasis.
- Assessment of the impact of ORMDL dysregulation on cancer cell behavior and therapeutic resistance.
Main Results:
- Dysregulated ORMDL expression disrupts sphingolipid metabolism, potentially triggering ER stress and impairing autophagy.
- ORMDL protein alterations are linked to tumor cell proliferation, invasiveness, and therapy resistance.
- ORMDL functions influence key pathways in tumor development and progression.
Conclusions:
- ORMDL proteins are implicated in cancer pathogenesis and may serve as valuable biomarkers.
- Targeting ORMDL proteins or their metabolic pathways presents a promising avenue for novel cancer therapies.
- Further research into ORMDLs' roles in the tumor microenvironment and immune interactions is warranted for personalized medicine.
Related Concept Videos
02:23Abnormal Proliferation
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...